{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:59:13Z","timestamp":1790913553735,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":130,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004561","name":"Ministry of Science and Higher Education of the Republic of Kazakhstan","doi-asserted-by":"publisher","award":["BR27195585"],"award-info":[{"award-number":["BR27195585"]}],"id":[{"id":"10.13039\/501100004561","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101244","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:26:25Z","timestamp":1778765185000},"page":"101244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Natural and in vitro-generated regulatory T-cell subsets differentially modulate phenotype and drug response in K562 leukemic cells"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3771-423X","authenticated-orcid":false,"given":"Yekaterina O.","family":"Ostapchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiya A.","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anzhelika V.","family":"Lushova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raikhan","family":"Tleulieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurshat","family":"Abdolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikyn","family":"Kali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya V.","family":"Perfilyeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101244_bib0001","doi-asserted-by":"crossref","DOI":"10.4161\/onci.24521","article-title":"The role of FOXP3 in disease progression in colorectal cancer patients","volume":"2","author":"Grimmig","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ctarc.2026.101244_bib0002","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1200\/JCO.2008.17.9036","article-title":"FOXP3 expression and overall survival in breast cancer","volume":"27","author":"Merlo","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0003","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00262-012-1348-8","article-title":"Up-regulation of Foxp3 participates in progression of cervical cancer","volume":"62","author":"Zeng","year":"2013","journal-title":"Cancer. Immunol. Immunther."},{"key":"10.1016\/j.ctarc.2026.101244_bib0004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.semcancer.2012.03.004","article-title":"What are regulatory T cells (Treg) regulating in cancer and why?","volume":"22","author":"Whiteside","year":"2012","journal-title":"Semin. Cancer. Biol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s12282-018-0874-4","article-title":"Functional heterogenity of circulating T regulatory cell subsets in breast cancer patients","volume":"25","author":"Ostapchuk","year":"2018","journal-title":"Breast. Cancer"},{"key":"10.1016\/j.ctarc.2026.101244_bib0006","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3389\/fimmu.2013.00190","article-title":"Natural and induced T regulatory cells in cancer","volume":"4","author":"Adeegbe","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0007","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10517-015-3038-y","article-title":"Content of HLA-G(+) T cells in the peripheral blood from healthy women and breast cancer patients","volume":"159","author":"Ostapchuk","year":"2015","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.ctarc.2026.101244_bib0008","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","author":"Miyara","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.ctarc.2026.101244_bib0009","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ni.1818","article-title":"Regulatory T cells exert checks and balances on self tolerance and autoimmunity","volume":"11","author":"Wing","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0010","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4\u207aCD25\u207b naive T cells to CD4\u207aCD25\u207a regulatory T cells by TGF-\u03b2 induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ctarc.2026.101244_bib0011","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.178.4.2018","article-title":"IL-2 is essential for TGF-\u03b2 to convert naive CD4\u207aCD25\u207b cells to CD4\u207aCD25\u207aFoxp3\u207a regulatory T cells","volume":"178","author":"Zheng","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0012","first-page":"39","article-title":"Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications","volume":"380","author":"Roncarolo","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0013","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1158\/1078-0432.CCR-08-3010","article-title":"Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia","volume":"15","author":"Szczepanski","year":"2009","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.ctarc.2026.101244_bib0014","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ijc.25791","article-title":"Elevated frequencies of CD4+CD25+CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia","volume":"129","author":"Shenghui","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ctarc.2026.101244_bib0015","first-page":"90","article-title":"Regulatory T cells in pediatric AML are associated with disease load and their serial assessment suggests role in leukemogenesis","volume":"10","author":"Bansal","year":"2020","journal-title":"Am. J. Blood. Res."},{"key":"10.1016\/j.ctarc.2026.101244_bib0016","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1292404","article-title":"CD4+CD25highCD127low\/-FoxP3+ regulatory T cell subpopulations in the bone marrow and peripheral blood of children with ALL: brief report","volume":"2018","author":"Nied\u017awiecki","year":"2018","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ctarc.2026.101244_bib0017","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/imm.12237","article-title":"Critical stoichiometric ratio of CD4(+) CD25(+) FoxP3(+) regulatory T cells and CD4(+) CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia","volume":"142","author":"Bhattacharya","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.ctarc.2026.101244_bib0018","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1179\/1607845415Y.0000000025","article-title":"Increased regulatory T cells in acute lymphoblastic leukemia patients","volume":"20","author":"Idris","year":"2015","journal-title":"Hematology"},{"key":"10.1016\/j.ctarc.2026.101244_bib0019","first-page":"180","article-title":"Regulatory T-cell trafficking and prognostic significance in leukemia","volume":"1","author":"Mailloux","year":"2013","journal-title":"Cancer. Immunol. Res."},{"key":"10.1016\/j.ctarc.2026.101244_bib0020","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/blood-2005-02-0642","article-title":"Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy","volume":"106","author":"Beyer","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101244_bib0021","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.leukres.2010.08.010","article-title":"Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease","volume":"35","author":"D\u2019Arena","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ctarc.2026.101244_bib0022","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10147-013-0615-9","article-title":"Prognostic value of regulatory T cells in newly diagnosed chronic myeloid leukemia patients","volume":"19","author":"Zahran","year":"2014","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0023","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/sj.leu.2404522","article-title":"Increased frequencies of CD4(+)CD25(high) T(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia","volume":"21","author":"Nadal","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.ctarc.2026.101244_bib0024","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/s41375-018-0175-0","article-title":"Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML","volume":"32","author":"Br\u00fcck","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.ctarc.2026.101244_bib0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2141.2010.08453.x","article-title":"Quantitative and functional analyses of CD4+CD25+FoxP3+ regulatory T cells in chronic phase chronic myeloid leukaemia patients at diagnosis and on imatinib mesylate","volume":"153","author":"Bachy","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0026","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5045\/br.2018.53.4.294","article-title":"Overexpression of indoleamine 2,3-dioxygenase correlates with regulatory T cell phenotype in acute myeloid leukemia patients with normal karyotype","volume":"53","author":"Arandi","year":"2018","journal-title":"Blood. Res."},{"key":"10.1016\/j.ctarc.2026.101244_bib0027","first-page":"5081","article-title":"Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair antileukemic immune responses by inducing regulatory T cells in acute myeloid leukemia","volume":"109","author":"Curti","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101244_bib0028","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1182\/bloodadvances.2021006195","article-title":"4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells","volume":"6","author":"Swatler","year":"2022","journal-title":"Blood. Adv."},{"key":"10.1016\/j.ctarc.2026.101244_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2025.110638","article-title":"Serum cytokine profiling identifies IL-17A and IL-10 as prognostic biomarkers for disease outcome in pediatric acute lymphoblastic leukemia","volume":"282","author":"Ye","year":"2026","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0030","first-page":"1480","article-title":"Blood cytokine levels in acute myelogenous leukemia: association with disease activity","volume":"9","author":"Bruserud","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.ctarc.2026.101244_bib0031","first-page":"1189","article-title":"Serum interleukin-10 levels in patients affected with multiple-myeloma - correlation with the monoclonal component and disease progression","volume":"6","author":"Ameglio","year":"1995","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0032","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood.V82.7.2169.2169","article-title":"Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor","volume":"82","author":"Blay","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101244_bib0033","article-title":"Increased serum level of interleukin-10 predicts poor survival and early recurrence in patients with peripheral T-cell lymphomas","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0034","first-page":"60","article-title":"Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma","volume":"17","author":"Lech-Maranda","year":"2006","journal-title":"Eur. Cytokine. Netw."},{"key":"10.1016\/j.ctarc.2026.101244_bib0035","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1182\/blood.2024028194","article-title":"Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4+ T cells","volume":"146","author":"Venkatesh","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101244_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/ebm.2025.10235","article-title":"Bone marrow immune cells and drug resistance in acute myeloid leukemia","volume":"250","author":"Zhang","year":"2025","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ctarc.2026.101244_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1703211","article-title":"Regulatory T cells in cancer: from immunosuppression to therapeutic targeting","volume":"16","author":"Basurto-Olvera","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0038","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.4049\/jimmunol.1402898","article-title":"IL-10 potentiates differentiation of human induced regulatory T cells via STAT3 and Foxo1","volume":"195","author":"Hsu","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0039","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-60761-869-0_3","article-title":"Methods for in vitro generation of human type 1 regulatory T cells","volume":"677","author":"Gregori","year":"2011","journal-title":"Methods. Mol. Biol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0040","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ctarc.2026.101244_bib0041","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-230X(06)97011-0","article-title":"PDGF receptors as targets in tumor treatment","volume":"97","author":"Ostman","year":"2007","journal-title":"Adv. Cancer. Res."},{"key":"10.1016\/j.ctarc.2026.101244_bib0042","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s00018-012-1085-3","article-title":"Vascular endothelial growth factor signaling in acute myeloid leukemia","volume":"70","author":"Kampen","year":"2013","journal-title":"Cell. Mol. Life. Sci."},{"key":"10.1016\/j.ctarc.2026.101244_bib0043","first-page":"1","article-title":"Human ABCG2: structure, function, and its role in multidrug resistance","volume":"3","author":"Mo","year":"2012","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0044","first-page":"1209","article-title":"ABCG2 expression in acute myeloid leukemia is associated with decreased intracellular drug accumulation","volume":"13","author":"de Jonge-Peeters","year":"2007","journal-title":"Clin. Cancer. Res."},{"key":"10.1016\/j.ctarc.2026.101244_bib0045","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.18632\/oncotarget.23231","article-title":"Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K\/AKT\/mTOR pathway","volume":"9","author":"Tu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctarc.2026.101244_bib0046","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-016-1133-7","article-title":"Single-cell epigenomic variability reveals functional cancer heterogeneity","volume":"18","author":"Litzenburger","year":"2017","journal-title":"Genome. Biol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0047","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3390\/jpm12081235","article-title":"CD24: a novel target for cancer immunotherapy","volume":"12","author":"Panagiotou","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.ctarc.2026.101244_bib0048","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41556-020-0507-y","article-title":"Overcoming Wnt\u2013\u03b2-catenin dependent anticancer therapy resistance in leukaemia stem cells","volume":"22","author":"Perry","year":"2020","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0049","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2026.101244_bib0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.31768\/2312-8852.2015.37(1):70-72","article-title":"Dyagil IS: functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy","volume":"37","author":"Sviezhentseva","year":"2015","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0051","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood-2008-05-158253","article-title":"Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib","volume":"113","author":"Yong","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101244_bib0052","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2013-10-533398","article-title":"CD16xCD33 bispecific killer cell engager enhances NK cell\u2013mediated immunotherapy against acute myeloid leukemia","volume":"123","author":"Gleason","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101244_bib0053","series-title":"Leukemia","article-title":"Myeloid\/lymphoid neoplasms with eosinophilia and platelet-derived growth factor receptor alpha (PDGFRA) rearrangement","author":"Kaur","year":"2022"},{"key":"10.1016\/j.ctarc.2026.101244_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114491","article-title":"New insights about the PDGF\/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies","volume":"161","author":"Pandey","year":"2023","journal-title":"Biomed. PharmacOther."},{"key":"10.1016\/j.ctarc.2026.101244_bib0055","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-025-02249-0","article-title":"Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives","volume":"10","author":"Lee","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ctarc.2026.101244_bib0056","series-title":"Madame Curie Bioscience Database","article-title":"Vascular endothelial growth factor (VEGF) and its role in non-endothelial cells: autocrine signalling by VEGF","author":"Duffy","year":"2000"},{"key":"10.1016\/j.ctarc.2026.101244_bib0057","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.leukres.2007.10.005","article-title":"Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia","volume":"32","author":"Liersch","year":"2008","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ctarc.2026.101244_bib0058","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5582\/irdr.2015.01048","article-title":"The progress of angiogenic factors in the development of leukemias","volume":"5","author":"Han","year":"2016","journal-title":"Intractable. Rare. Dis. Res."},{"key":"10.1016\/j.ctarc.2026.101244_bib0059","doi-asserted-by":"crossref","first-page":"7147","DOI":"10.3390\/ijms24087147","article-title":"ABCG2 in acute myeloid leukemia: old and new perspectives","volume":"24","author":"Damiani","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101244_bib0060","first-page":"14","article-title":"Review of cellular resistance to gemcitabine","volume":"1","author":"Jordheim","year":"2018","journal-title":"Cancer. Drug. Resist."},{"key":"10.1016\/j.ctarc.2026.101244_bib0061","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.ctarc.2026.101244_bib0062","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/antiox7010013","article-title":"Reactive oxygen species and mitochondrial dynamics: the yin and Yang of mitochondrial dysfunction and cancer progression","volume":"7","author":"Je\u017eek","year":"2018","journal-title":"Antioxidants"},{"key":"10.1016\/j.ctarc.2026.101244_bib0063","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/cancers13030421","article-title":"Immunophenotype of gastric tumors unveils a pleiotropic role of regulatory T cells in tumor development","volume":"13","author":"Rocha","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101244_bib0064","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00262-021-02872-0","article-title":"Regulatory T cells promote glioma cell stemness through TGF-\u03b2\u2013NF-\u03bab\u2013IL6\u2013STAT3 signaling","volume":"70","author":"Liu","year":"2021","journal-title":"Cancer. Immunol. Immunther."},{"key":"10.1016\/j.ctarc.2026.101244_bib0065","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.3389\/fimmu.2019.01741","article-title":"Regulatory T cells promote overexpression of Lgr5 on gastric cancer cells via TGF-\u03b21 and confer poor prognosis in gastric cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0066","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.786728","article-title":"TGF-\u03b2 signaling and resistance to cancer therapy","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0067","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161067","article-title":"The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions","volume":"14","author":"Carlini","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101244_bib0068","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.ctarc.2026.101244_bib0069","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1267697","article-title":"Lineage origin and transcriptional control of autoantigen-specific T-regulatory type 1 cells","volume":"14","author":"Angelats","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:47:56Z","timestamp":1790912876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":69,"alternative-id":["S2468294226001553"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101244","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural and in vitro-generated regulatory T-cell subsets differentially modulate phenotype and drug response in K562 leukemic cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101244","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101244"}}